解决在中国扩大人类乳头瘤病毒疫苗接种的障碍:进展和前进的道路
Xue-Lian Zhao1, Shang-Ying Hu1, Jia-Wei Hu1
1Department of Epidemiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, 17 South Panjiayuan Lane, P.O. Box 2258, Beijing, 100021, China.
Infectious diseases of poverty
|September 22, 2023
概括
中国中国中国中国.
科学领域:
- 公共卫生 公共卫生
- 疫苗学 疫苗学 疫苗学
- 流行病学 流行病学
背景情况:
- 人类乳头瘤病毒 (HPV) 疫苗对于预防宫癌至关重要.
- 中国已经投入了超过15年的时间来开发国内HPV疫苗和疫苗接种计划.
- 在HPV疫苗接种规模扩大方面的进展面临着几个挑战.
研究的目的:
- 审查中国HPV疫苗接种计划的进展和挑战.
- 确定扩大HPV疫苗接种和影响的关键策略.
- 为中国未来的宫癌预防工作提供信息.
主要方法:
- 审查中国国家HPV疫苗接种倡议和政策.
- 对HPV疫苗扩展障碍的分析.
- 检查当地的疫苗有效性和实施策略的证据.
主要成果:
- 中国在HPV疫苗研发和试点计划方面取得了重大进展.
- 关键的挑战包括疫苗的可用性,成本和公平的获取.
- 需要证据支持一次剂量计划和关注服务不足的人群.
结论:
- 解决供应,财务和接入障碍对于在中国扩大HPV疫苗接种至关重要.
- 进一步研究单剂量疗效和现实世界的监测是必不可少的.
- 为了有效控制宫癌,需要综合战略,包括二次预防.
相关概念视频
Cancer Vaccines
396
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
396
Vaccinations
44.6K
Overview
44.6K


